Takeda Pharmaceutical Company Limited Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement
Takeda Pharmaceutical Company Limited (TKPHF) had Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement of JPY 4.05 thousand as of 2019-03-31, per its 20-F filed 2019-06-27.
Discontinued › Notes › Compensation Related Costs
ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement · last filed 2019-06-27
- 2019-03-31: Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement 4.05K JPY.
- 2018-03-31: Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement 4.05K JPY.
- 2017-03-31: Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement 4.03K JPY.
- 2016-03-31: Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement 3.92K JPY.
| Period end | Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement |
|---|---|
| 2019-03-31 | 4.05K JPY 20-F · filed 2019-06-27 |
| 2018-03-31 | 4.05K JPY 20-F · filed 2019-06-27 |
| 2017-03-31 | 4.03K JPY 20-F · filed 2019-06-27 |
| 2016-03-31 | 3.92K JPY 20-F · filed 2019-06-27 |